Literature DB >> 3020083

Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens.

J M Middeldorp, J Jongsma, T H The.   

Abstract

This paper describes an improved method for the in vitro detection of antibodies specifically directed against human cytomegalovirus (CMV)-induced membrane antigens present on the surface of CMV-infected fibroblasts (CMV-MA). Viable cells were found to be essential for specific visualization of CMV-MA staining. The addition of divalent cations (2.6 mM Ca2+ and 2.2 mM Mg2+) and glucose (180 mM) to the incubation and washing buffers improved the viability and morphology of the cells and increased the cell yield at the end of the assay. Clustering of antigen-antibody complexes on the surface of viable CMV-infected cells was prevented by low-temperature incubation (0 to 4 degrees C) rather than by the addition of agents which act on the metabolism of the cell. No interaction with the CMV-induced Fc receptor was observed at 0 degrees C with either human sera or murine monoclonal antibodies. The specificity of the CMV-MA reaction was confirmed by using monoclonal antibodies to CMV nuclear, cytoplasmic, and membrane-associated antigens. Furthermore, a microplate modification of the membrane fluorescence test is described which is suitable for multisample screening purposes. This method can be applied to the determination of anti-CMV-MA antibody titers in human sera and to the screening of hybridoma supernatants for the presence of antibodies with specificity for CMV-MA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020083      PMCID: PMC268924          DOI: 10.1128/jcm.24.3.405-413.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Use of the local anesthetic lidocaine for cell harvesting and subcultivation.

Authors:  M Rabinovitch; M J DeStefano
Journal:  In Vitro       Date:  1975 Nov-Dec

2.  Membrane glycoproteins and antigens induced by human cytomegalovirus.

Authors:  M F Stinski; E S Mocarski; D R Thomsen; M L Urbanowski
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

3.  Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

Authors:  J A Zaia; M N Oxman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

4.  Cytomegalovirus-induced membrane antigens in productively infected cells.

Authors:  I Boldogh; E Gönczöl; L Váczi
Journal:  Acta Microbiol Acad Sci Hung       Date:  1977

5.  Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus.

Authors:  A A Rahman; M Teschner; K K Sethi; H Brandis
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

6.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

7.  Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method.

Authors:  T H The; T E Feltkamp
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

8.  Demonstration of IgG EA (early antigen) and IgM MA (membrane antigen) antibodies in CMV infection of healthy infants and in those with liver disease.

Authors:  Y Numazaki; T Oshima; A Tanaka; T Konno; Y Tazawa; M Karita; A Ishii; K Hirota; N Watabe; N Ishida
Journal:  J Pediatr       Date:  1980-10       Impact factor: 4.406

9.  The antibody-induced clustering and endocytosis of HLA antigens on cultured human fibroblasts.

Authors:  C Huet; J F Ash; S J Singer
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

10.  Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.

Authors:  T H The; G Klein; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

View more
  2 in total

1.  Natural killing of fibroblasts infected with low-passage clinical isolates of human cytomegalovirus.

Authors:  S Bandyopadhyay; S H Oh; S Michelson; D S Miller; J L Virelizier; S E Starr
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

2.  Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.

Authors:  M Ohlin; B Plachter; V A Sundqvist; P G Steenbakkers; J M Middeldorp; C A Borrebaeck
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.